CCO Expert Recap

New Agents

Source: 2007 Conference on Retroviruses and Opportunistic Infections*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Investigational Antiretrovirals: Update From Los Angeles

Faculty:

Joel E. Gallant, MD, MPHJudith S. Currier, MD, MScJoseph J. Eron, Jr., MD
  • Joel E. Gallant, MD, MPH
  • Judith S. Currier, MD, MSc
  • Joseph J. Eron, Jr., MD
Sally Hodder, MDDonald P. Kotler, MDWilliam G. Powderly, MD
  • Sally Hodder, MD
  • Donald P. Kotler, MD
  • William G. Powderly, MD
Kimberly Y. Smith, MD, MPHAndrew R. Zolopa, MD
  • Kimberly Y. Smith, MD, MPH
  • Andrew R. Zolopa, MD

CME CREDIT INFORMATION

Release Date: 05/02/07

Expiration Date: 05/01/08


Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.5 Nursing CE credits

Status: Please log in to view status
Begin the CCO Expert Recap

Joel E. Gallant, MD, MPH, offers expert analysis of the most clinically relevant studies on novel antiretroviral agents presented at the 2007 Conference on Retroviruses and Opportunistic Infections.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify agents in new classes of antiretroviral agents
  • Describe the results of recent studies of investigational antiretroviral agents
  • Discuss the implications of recent studies of investigational antiretroviral agents for patient management strategies

Slideset

CCO Slideset – Investigational Antiretrovirals: Update From Los Angeles


Format: Microsoft PowerPoint (.ppt) | File size: 701 KB


Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.